AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

AFT PHARMACEUTICALS LTD

2.340

-0.110-4.49%

Volume:2.00K

Turnover:4.90K

Market Cap:245.39M

PE:24.56

High:2.560

Open:2.550

Low:2.340

Close:2.450

Loading ...

Overview Company News Filings

AFT Pharmaceuticals Agrees Partnership for Iron Deficiency Therapy Development

MT Newswires Live

Strategy launches $21b stock offering, Coinbase expands, Binance founder refutes Trump story | Weekly Recap

AFT Pharmaceuticals Limited (NZSE:AFT) insiders seem bullish, own 69% and have been buying more recently

Simply Wall St.

Is Weakness In AFT Pharmaceuticals Limited (NZSE:AFT) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Simply Wall St.

AFT Pharmaceuticals Expects Record Fiscal 2025 Sales Despite Disruptions in H1

MT Newswires Live

ASX Preview: Australian Shares Set to Open Lower Amid Wall Street Losses

MT Newswires Live

AFT Pharmaceuticals (NZSE:AFT) shareholders have endured a 34% loss from investing in the stock three years ago

Simply Wall St.

Urgent warning for parents as horrifying trend among kids emerges online

Sydney Morning Herald

Pleasing Signs As A Number Of Insiders Buy AFT Pharmaceuticals Stock

Simply Wall St.

Young people involved in one-fifth of Australian terrorism cases, intelligence chief says

New Zealand Equities Flat Amid Lack of Headlines; Infratil Rises on Planned Infrastructure Bonds Offer

MT Newswires Live

AFT Pharmaceuticals Swings to Loss in Six Months Ended September Amid Demand Disruptions

MT Newswires Live

Gold miner confirms CEO held by Mali’s military junta, shares slide

The Sydney Morning Herald

Australian police search Sydney PwC office over tax leak probe

AFT Pharmaceuticals Flags Under NZ$2 Million Operating Loss in H1; Shares Down 8%

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/AFP.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AFP.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AFP.AU\",,,,,undefined,":{"symbol":"AFP.AU","market":"AU","secType":"STK","nameCN":"AFT PHARMACEUTICALS LTD","latestPrice":2.34,"timestamp":1745302320000,"preClose":2.45,"halted":0,"volume":2000,"delay":0,"nameEN":"AFT PHARMACEUTICALS LTD","floatShares":29162352,"shares":104866260,"eps":0.09525810814613328,"marketStatus":"Not Yet Opened","change":-0.11,"latestTime":"04-22 16:12:00 AEST","open":2.55,"high":2.56,"low":2.34,"amount":4902,"amplitude":0.089796,"askPrice":2.85,"askSize":1606,"bidPrice":2.28,"bidSize":15,"shortable":3,"etf":0,"ttmEps":0.09525810814613328,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1745366400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":2.45,"dividendRate":0.006402,"openAndCloseTimeList":[[1745280000000,1745301600000]],"volumeRatio":1.25,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AFP.AU\",,,,,undefined,":{"symbol":"AFP.AU","floatShares":29162352,"roa":"7.82%","roe":"14.40%","lyrEps":0.139401,"volumeRatio":1.25,"shares":104866260,"dividePrice":0.014985,"high":2.56,"amplitude":0.089796,"preClose":2.45,"low":2.34,"week52Low":2.15,"pbRate":"3.13","psRate":"1.32","week52High":3.16,"institutionHeld":0,"latestPrice":2.34,"committee":-0.981493,"eps":0.09525810814613328,"divideRate":0.006402,"volume":2000,"delay":0,"ttmEps":0.09525810814613328,"open":2.55,"prevYearClose":2.55,"prevWeekClose":2.45,"prevMonthClose":2.3,"prevQuarterClose":2.3,"fiveDayClose":2.45,"twentyDayClose":2.3,"sixtyDayClose":2.585},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AFP.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2523870619","title":"AFT Pharmaceuticals Agrees Partnership for Iron Deficiency Therapy Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2523870619","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523870619?lang=en_us&edition=fundamental","pubTime":"2025-03-31 07:23","pubTimestamp":1743377026,"startTime":"0","endTime":"0","summary":"AFT Pharmaceuticals  agreed to progress its injectable iron deficiency therapy to phase three trials as part of a new deal with Belgian firm Hyloris Pharmaceuticals, according to  Monday filings with the Australian and New Zealand bourses.It completed phase 2b trials for the therapy. The terms of an original conditional agreement the firm first disclosed in October 2024, call for both parties to secure an exclusive global intellectual property license upon meeting pre-specified conditions.Hyloris will oversee product formulation, manufacturing, and the coordination of commercialization in Europe. AFT will manage the clinical trials, execution, and commercialization outside Europe.Phase three clinical trials involving around 1,000 patients will be conducted in the US, Europe, India, and China to investigate the product's efficacy and safety.Its shares rose almost 1% in early trading on the New Zealand bourse.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","AFP.AU","AFT"],"gpt_icon":0},{"id":"2519705803","title":"Strategy launches $21b stock offering, Coinbase expands, Binance founder refutes Trump story | Weekly Recap","url":"https://stock-news.laohu8.com/highlight/detail?id=2519705803","media":"cryptonews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519705803?lang=en_us&edition=fundamental","pubTime":"2025-03-16 18:21","pubTimestamp":1742120476,"startTime":"0","endTime":"0","summary":"Today’s edition of the weekly recap covers Strategy’s massive stock offering to fund Bitcoin purchases, Coinbase’s hiring plans under the Trump administration, and growing crypto cooperation between Latin American nations.Michael Saylor’s Strategy announced a $21 billion at-the-market offering of its Series A preferred stock , with proceeds primarily designated for additional Bitcoin  purchases.While Strategy maintains its position as a major corporate Bitcoin holder, with just under 500,000 BTC, its stock is on a downtrend this year.CEO Brian Armstrong announced plans to add approximately 1,000 U.S. employees in 2025. Yes, there’s current weakness, but President Trump is “breathing life back into the crypto industry,” he said.Armstrong’s regional director for Southeast Asia, Hassan Ahmed, is also bullish on the long-term outlook for the digital asset industry.Coinbase secured registration with India’s Financial Intelligence Unit , advancing its return to the Indian market after previo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://crypto.news/strategy-coinbase-binance-toncoin-weekly-recap/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"crypto_news_highlight","symbols":["AFP.AU","BK7096","09008","03179","STRK","09179","BK4596","03008","BK4539","LU1861559042.SGD","03009","BK4601","ETHV","03439","BK4554","CETH","03042","BTC.AU","09009","BK1611","09046","83042","LDO.USD.HKCC","FETH","COIN","BK4585","TON.AU","BK4600","09042","09439","BTC","TON.USD.CC","BTC.USD.CC","BK4023","ETH","EZET","BK4516","BK4551","03046","ETH.USD.HKCC","MSTR","TON.USD.HKCC","QETH","BTC.USD.HKCC","BK4112","ETH.USD.CC","APT.USD.CC","APT.USD.HKCC"],"gpt_icon":1},{"id":"2512510424","title":"AFT Pharmaceuticals Limited (NZSE:AFT) insiders seem bullish, own 69% and have been buying more recently","url":"https://stock-news.laohu8.com/highlight/detail?id=2512510424","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512510424?lang=en_us&edition=fundamental","pubTime":"2025-02-20 08:22","pubTimestamp":1740010966,"startTime":"0","endTime":"0","summary":"AFT Pharmaceuticals' significant insider ownership suggests inherent interests in company's expansion. 69% of the company is held by a single shareholder . If you want to know who really controls AFT Pharmaceuticals Limited , then you'll have to look at the makeup of its share registry. The group holding the most number of shares in the company, around 69% to be precise, is individual insiders. Put another way, the group faces the maximum upside potential .It's interesting to note that insiders have been buying shares recently. This could signal that stock prices could go up and insiders are here for it.Let's delve deeper into each type of owner of AFT Pharmaceuticals, beginning with the chart below.While the precise definition of an insider can be subjective, almost everyone consi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aft-pharmaceuticals-limited-nzse-aft-002246868.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7096","AFT","AFP.AU"],"gpt_icon":0},{"id":"2506892985","title":"Is Weakness In AFT Pharmaceuticals Limited (NZSE:AFT) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?","url":"https://stock-news.laohu8.com/highlight/detail?id=2506892985","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506892985?lang=en_us&edition=fundamental","pubTime":"2025-01-28 03:31","pubTimestamp":1738006281,"startTime":"0","endTime":"0","summary":"It is hard to get excited after looking at AFT Pharmaceuticals'  recent performance, when its stock has declined 16% over the past three months. However, a closer look at its sound financials might cause you to think again. Given that fundamentals usually drive long-term market outcomes, the company is worth looking at. Particularly, we will be paying attention to AFT Pharmaceuticals'  ROE today.Return on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing the company's capital. Put another way, it reveals the company's success at turning shareholder investments into profits.So, based on the above formula, the ROE for AFT Pharmaceuticals is:. Is AFT Pharmaceuticals Making Efficient Use Of Its Profits?AFT Pharmaceuticals' three-year median payout ratio to shareholders is 11% , which is on the lower side, so it seems like the management is reinvesting profits heavily to grow its business.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/weakness-aft-pharmaceuticals-limited-nzse-193121403.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["AFT","BK7096","AFP.AU"],"gpt_icon":0},{"id":"2503195390","title":"AFT Pharmaceuticals Expects Record Fiscal 2025 Sales Despite Disruptions in H1","url":"https://stock-news.laohu8.com/highlight/detail?id=2503195390","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503195390?lang=en_us&edition=fundamental","pubTime":"2025-01-13 07:04","pubTimestamp":1736723093,"startTime":"0","endTime":"0","summary":"AFT Pharmaceuticals  expects to achieve record sales of more than AU$200 million in fiscal 2025, up from AU$56 million in fiscal 2015 and AU$106 million in fiscal 2020, according to a Monday filing with the Australian and New Zealand bourses.The upbeat outlook comes despite sales disruptions seen in the first half. The pharmaceutical company said it targets to achieve AU$300 million turnover on a rolling annual basis by the end of 2027.AFT Pharmaceuticals' Kiwi shares were up past 1% in recent Monday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AFP.AU","AFT"],"gpt_icon":0},{"id":"2503392194","title":"ASX Preview: Australian Shares Set to Open Lower Amid Wall Street Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2503392194","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503392194?lang=en_us&edition=fundamental","pubTime":"2025-01-13 05:53","pubTimestamp":1736718794,"startTime":"0","endTime":"0","summary":"Australian shares are headed for a lower open on Monday as investors are likely to track losses from Wall Street last Friday in the wake of the US jobs report.The ANZ-Indeed Job Ads report for December 2024 is slated for release at 11:30 am Sydney time. The Melbourne Institute's monthly inflation gauge is also scheduled at around 12 pm.Last Jan. 10, the Nasdaq tumbled 2.3%, while the Dow Jones Industrial Average and the S&P 500 lost 1.9% each after data showed that the country added more jobs than projected in December 2024.In corporate news, AFT Pharmaceuticals  forecast record sales of more than AU$200 million in fiscal 2025, up from AU$56 million and AU$106 million turnovers in fiscal 2015 and fiscal 2020, respectively.Deep Yellow  issued 124,263 fully paid ordinary shares following the exercise of 124,263 vested employee performance rights.Australia's benchmark index was down 0.4%, or 35.10 points, to close at 8,294.10 on Jan. 10.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7083","DYL.AU","BK7096","XAO.AU","AFP.AU","XKO.AU","XJO.AU"],"gpt_icon":0},{"id":"2501214367","title":"AFT Pharmaceuticals (NZSE:AFT) shareholders have endured a 34% loss from investing in the stock three years ago","url":"https://stock-news.laohu8.com/highlight/detail?id=2501214367","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501214367?lang=en_us&edition=fundamental","pubTime":"2025-01-07 10:21","pubTimestamp":1736216465,"startTime":"0","endTime":"0","summary":"For many investors, the main point of stock picking is to generate higher returns than the overall market. But its virtually certain that sometimes you will buy stocks that fall short of the market average returns. Unfortunately, that's been the case for longer term AFT Pharmaceuticals Limited  shareholders, since the share price is down 35% in the last three years, falling well short of the market decline of around 0.8%.It's worthwhile assessing if the company's economics have been moving in lockstep with these underwhelming shareholder returns, or if there is some disparity between the two. So let's do just that.In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. By comparing earnings per share  and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.During the unfortunate three years of share price decline, AFT Pharmaceu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aft-pharmaceuticals-nzse-aft-shareholders-022105256.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7096","AFT","AFP.AU"],"gpt_icon":0},{"id":"2492437636","title":"Urgent warning for parents as horrifying trend among kids emerges online","url":"https://stock-news.laohu8.com/highlight/detail?id=2492437636","media":"Sydney Morning Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492437636?lang=en_us&edition=fundamental","pubTime":"2024-12-20 08:50","pubTimestamp":1734655836,"startTime":"0","endTime":"0","summary":"Parents have been issued an urgent warning after a horrifying trend no child should ever be exposed to emerged online.","market":"us","thumbnail":"https://images.perthnow.com.au/publication/C-17147640/e4c0cc161fb3d3150ff42c16ccf2d02e9a385029-16x9-x0y1w1280h720.jpg","type":0,"news_type":0,"thumbnails":["https://images.perthnow.com.au/publication/C-17147640/e4c0cc161fb3d3150ff42c16ccf2d02e9a385029-16x9-x0y1w1280h720.jpg"],"rights":{"source":"perthnow_stock","url":"https://www.perthnow.com.au/business/urgent-warning-for-parents-as-horrifying-trend-among-kids-emerges-online-c-17147640","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.perthnow.com.au/business/urgent-warning-for-parents-as-horrifying-trend-among-kids-emerges-online-c-17147640","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"perthnow_stock","symbols":["BK7096","AFP.AU"],"gpt_icon":0},{"id":"2492601525","title":"Pleasing Signs As A Number Of Insiders Buy AFT Pharmaceuticals Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2492601525","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492601525?lang=en_us&edition=fundamental","pubTime":"2024-12-17 11:52","pubTimestamp":1734407522,"startTime":"0","endTime":"0","summary":"When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase stock, like in AFT Pharmaceuticals Limited's  instance, it's good news for shareholders.While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, logic dictates you should pay some attention to whether insiders are buying or selling shares.Check out our latest analysis for AFT Pharmaceuticals. It is good to see recent purchasing. And the longer term insider transactions also give us confidence. When combined with notable insider ownership, these factors suggest AFT Pharmaceuticals insiders are well aligned, and quite possibly think the share price is too low. Nice!","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/H9sVDVM9mi9ws1HvXhxW7w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/H9sVDVM9mi9ws1HvXhxW7w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pleasing-signs-number-insiders-buy-035202953.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["AFT","AFP.AU","BK7096"],"gpt_icon":0},{"id":"2489783455","title":"Young people involved in one-fifth of Australian terrorism cases, intelligence chief says","url":"https://stock-news.laohu8.com/highlight/detail?id=2489783455","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489783455?lang=en_us&edition=fundamental","pubTime":"2024-12-05 21:01","pubTimestamp":1733403660,"startTime":"0","endTime":"0","summary":"By Kirsty Needham      SYDNEY, Dec 6 (Reuters) - One in five priority counter-terrorism cases investigated by Australia involved youth, the country's spy chief said on Friday, as the \"Five Eyes\" intel","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XAO.AU","AFP.AU","BK7096","BK4576","BK4554","BK4508","XKO.AU","BK4551","XJO.AU","BK4077"],"gpt_icon":0},{"id":"2485811480","title":"New Zealand Equities Flat Amid Lack of Headlines; Infratil Rises on Planned Infrastructure Bonds Offer","url":"https://stock-news.laohu8.com/highlight/detail?id=2485811480","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485811480?lang=en_us&edition=fundamental","pubTime":"2024-11-21 12:43","pubTimestamp":1732164226,"startTime":"0","endTime":"0","summary":"New Zealand shares ended Thursday trade flat with a positive bias amid a mixed performance on Wall Street and a lack of catalyst domestically.The S&P/NZX 50 Index was little changed at 12,765.24. The ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7105","NZ50G.NZ","T10G.NZ","BK7134","AFP.AU","BK7006","NZ20C.NZ","BK7096","IFT.AU"],"gpt_icon":0},{"id":"2485248471","title":"AFT Pharmaceuticals Swings to Loss in Six Months Ended September Amid Demand Disruptions","url":"https://stock-news.laohu8.com/highlight/detail?id=2485248471","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485248471?lang=en_us&edition=fundamental","pubTime":"2024-11-21 11:59","pubTimestamp":1732161558,"startTime":"0","endTime":"0","summary":"AFT Pharmaceuticals  reported a net loss after tax of NZ$2.4 million for the six months to September, compared with a net profit of NZ$1.8 million in the year-earlier period on the back of demand disruptions, according to a Thursday filing with the New Zealand and Australian bourses.Operating revenue rose 4% to NZ$86.7 million, owing to double-digit sales growth in Australasia. Revenue in international and Asian markets fell due to reduced demand from key customers.Fiscal 2025 operating profit is expected to range from NZ$15 million to NZ$20 million, which AFT Pharmaceuticals Chair David Flacks said is lower than the company's expectations at the start of the year.AFT Pharmaceuticals' shares were up nearly 3% in recent Thursday trade in New Zealand.Price : $2.61, Change: $+0.07, Percent Change: +2.76%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AFT","AUD","LU0426417589.USD","BK7096","AFP.AU","LU0426412945.USD","LU1043141123.HKD","BK4125","LU0345774631.USD","LU2238339852.HKD","LU0994945656.USD"],"gpt_icon":0},{"id":"2482173249","title":"Gold miner confirms CEO held by Mali’s military junta, shares slide","url":"https://stock-news.laohu8.com/highlight/detail?id=2482173249","media":"The Sydney Morning Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482173249?lang=en_us&edition=fundamental","pubTime":"2024-11-11 11:57","pubTimestamp":1731297420,"startTime":"0","endTime":"0","summary":"Resolute Mining’s shares have taken a hit after the gold miner confirmed its chief executive, Terry Holohan, and two other employees are being held by Mali’s military junta in the landlocked African c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.smh.com.au/business/companies/gold-miner-confirms-ceo-held-by-mali-s-military-junta-shares-slide-20241111-p5kpjd.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"smh_stock","symbols":["AFP.AU","XKO.AU","XAO.AU","BK7096","XJO.AU"],"gpt_icon":0},{"id":"2480341648","title":"Australian police search Sydney PwC office over tax leak probe","url":"https://stock-news.laohu8.com/highlight/detail?id=2480341648","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480341648?lang=en_us&edition=fundamental","pubTime":"2024-11-04 11:31","pubTimestamp":1730691072,"startTime":"0","endTime":"0","summary":"By Renju Jose      SYDNEY, Nov 4  - Australian police on Monday searched the PwC Australia office in Sydney as part of a probe into a former partner who leaked confidential government tax plans to the firm and its clients.     A parliamentary inquiry earlier this year concluded the firm had shared the data internally and covered up its use.   \"This step is part of the existing investigation ... regarding the historical tax matter, and is an investigation into individuals who have left the firm,\" a PwC Australia spokesperson said in an email.   PwC Australia added that it had been working with the Australian Federal Police  to help with the searches and will continue to cooperate fully.   \"Out of respect for the AFP's work, we won't be commenting further,\" the spokesperson said.   Police in 2023 began investigating the \"big four\" accounting firm over the breaches, which forced out several partners including former PwC Australia CEO Tom Seymour, and led to the fire sale of its lucrative ","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XJO.AU","XKO.AU","BK7096","AFP.AU","XAO.AU"],"gpt_icon":0},{"id":"2480041906","title":"AFT Pharmaceuticals Flags Under NZ$2 Million Operating Loss in H1; Shares Down 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480041906","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480041906?lang=en_us&edition=fundamental","pubTime":"2024-11-01 12:00","pubTimestamp":1730433619,"startTime":"0","endTime":"0","summary":"AFT Pharmaceuticals  expects to incur an operating loss of below NZ$2 million for the six months ended Sept. 30, according to a Friday filing with the New Zealand bourse.The pharmaceuticals company attributed the first-half loss to lower sales amid a reduction in orders from large customers and a doctors' strike in South Korea, among other factors.AFT will report its interim results on Nov. 21.The company's shares were down more than 8% in recent trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AFP.AU","AFT"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AFP.AU\",params:#limit:5,,,undefined,":[{"date":"2024-06-19","symbol":"AFP.AU","amount":0.016,"announcedDate":"2024-05-23","type":"dividend","market":"AU","newRecordDate":"2024-06-20","defaultRemindTime":1718755200000,"name":"AFT PHARMACEUTICALS LTD","recordDate":"2024-07-04","payableDate":"2024-06-20","currency":"NZD","dateTimestamp":1718719200000,"payDate":"2024-07-04"},{"date":"2023-06-16","symbol":"AFP.AU","amount":0.011,"announcedDate":"2023-05-22","type":"dividend","market":"AU","newRecordDate":"2023-06-19","defaultRemindTime":1686873600000,"name":"AFT Pharmaceuticals","recordDate":"2023-07-04","payableDate":"2023-06-19","currency":"NZD","dateTimestamp":1686837600000,"payDate":"2023-07-04"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AFP.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2023-06-16","recordDate":"2023-06-19","paymentDate":"2023-07-04","value":0.011,"currency":"NZD"},{"executeDate":"2024-06-19","recordDate":"2024-06-20","paymentDate":"2024-07-04","value":0.016,"currency":"NZD"}]}}